Shlevin Harold H.

SEC source: 0001133416-26-000061 · form4.xml · derivative · entry 6

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 22,268 shares

Expires 2035-01-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29. 2025, as disclosed in the Issuers Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025

F3 · derivative.exercise_date: The options vested 100% on December 31, 2025.

SEC source: 0001133416-26-000061 · form4.xml · nonDerivative · entry 4

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,500

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29. 2025, as disclosed in the Issuers Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025

F4 · price: The shares were sold in multiple transactions at prices ranging from $5.00 to $5.12. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001133416-26-000061 · form4.xml · nonDerivative · entry 3

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,768

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29. 2025, as disclosed in the Issuers Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025

SEC source: 0001133416-26-000061 · form4.xml · derivative · entry 5

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,268

Underlying: Common Stock · 7,732 shares

Expires 2035-01-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29. 2025, as disclosed in the Issuers Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025

F3 · derivative.exercise_date: The options vested 100% on December 31, 2025.

SEC source: 0001133416-26-000061 · form4.xml · nonDerivative · entry 2

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,500

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29. 2025, as disclosed in the Issuers Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025

F2 · price: The shares were sold in multiple transactions at prices ranging from $5.00 to $5.01. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001133416-26-000061 · form4.xml · nonDerivative · entry 1

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,232

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29. 2025, as disclosed in the Issuers Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025

SEC source: 0001133416-26-000028 · form4.xml · derivative · entry 1

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2036-01-16

F1 · security: The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.

F2 · derivative.exercise_date: The options vest 100% on December 31, 2026.

SEC source: 0001133416-25-000067 · form4.xml · derivative · entry 4

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2032-01-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F3 · derivative.exercise_date: The options vested 100% on December 31, 2022..

SEC source: 0001133416-25-000067 · form4.xml · nonDerivative · entry 3

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,500

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F2 · price: The shares were sold in multiple transactions at prices ranging from $7.11 to $7.11. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001133416-25-000067 · form4.xml · nonDerivative · entry 2

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,206

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F2 · price: The shares were sold in multiple transactions at prices ranging from $7.11 to $7.11. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001133416-25-000067 · form4.xml · nonDerivative · entry 1

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,206

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

SEC source: 0001133416-25-000064 · form4.xml · derivative · entry 6

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,417 shares

Expires 2028-05-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F3 · derivative.exercise_date: The options vested as follows: 25% on each of June 30, 2018 and September 30, 2018, and 50% on December 31, 2018.

SEC source: 0001133416-25-000064 · form4.xml · nonDerivative · entry 4

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,206

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F2 · price: The shares were sold in multiple transactions at prices ranging from $6.25 to $6.40. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001133416-25-000064 · form4.xml · nonDerivative · entry 3

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,623

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

SEC source: 0001133416-25-000064 · form4.xml · derivative · entry 5

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,417

Underlying: Common Stock · 16,790 shares

Expires 2028-05-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F3 · derivative.exercise_date: The options vested as follows: 25% on each of June 30, 2018 and September 30, 2018, and 50% on December 31, 2018.

SEC source: 0001133416-25-000064 · form4.xml · nonDerivative · entry 2

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,206

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F2 · price: The shares were sold in multiple transactions at prices ranging from $6.25 to $6.40. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001133416-25-000064 · form4.xml · nonDerivative · entry 1

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,999

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

SEC source: 0001133416-25-000061 · form4.xml · derivative · entry 22

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,210

Underlying: Common Stock · 16,790 shares

Expires 2028-05-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F11 · derivative.exercise_date: The options vested as follows: 25% on each of June 30, 2018 and September 30, 2018, and 50% on December 31, 2018.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 15

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,206

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F12 · price: The shares were sold in multiple transactions at prices ranging from $6.25 to $6.31. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 14

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,996

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

SEC source: 0001133416-25-000061 · form4.xml · derivative · entry 21

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F6 · derivative.exercise_date: The options vested 100% on December 31, 2023.

SEC source: 0001133416-25-000061 · form4.xml · derivative · entry 20

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2031-03-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F5 · derivative.exercise_date: The options vested 100% on December 31, 2024.

SEC source: 0001133416-25-000061 · form4.xml · derivative · entry 19

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-01-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F5 · derivative.exercise_date: The options vested 100% on December 31, 2024.

SEC source: 0001133416-25-000061 · form4.xml · derivative · entry 18

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common stock · 20,000 shares

Expires 2032-01-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F4 · derivative.exercise_date: The options vested 100% on December 31, 2022.

SEC source: 0001133416-25-000061 · form4.xml · derivative · entry 17

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-03-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F3 · derivative.exercise_date: The options vested 100% on December 31, 2021.

SEC source: 0001133416-25-000061 · form4.xml · derivative · entry 16

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2031-03-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F2 · derivative.exercise_date: The options vested as follows: 25% on each of June 30, 2021, December 31, 2021, June 30, 2022, and December 31, 2022.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 13

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,206

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F7 · price: The shares were sold in multiple transactions at prices ranging from $6.00 to $6.05. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 12

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,206

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 11

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,206

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F10 · price: The shares were sold in multiple transactions at prices ranging from $6.00 to $6.08. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 10

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,206

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 9

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,206

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F8 · price: The shares were sold in multiple transactions at prices ranging from $5.69 to $6.05. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 8

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,206

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 7

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,206

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F9 · price: The shares were sold in multiple transactions at prices ranging from $5.69 to $6.034. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 6

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,206

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 5

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,206

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F9 · price: The shares were sold in multiple transactions at prices ranging from $5.69 to $6.034. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 4

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,206

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 3

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,206

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F8 · price: The shares were sold in multiple transactions at prices ranging from $5.69 to $6.05. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 2

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,206

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

SEC source: 0001133416-25-000061 · form4.xml · nonDerivative · entry 1

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,206

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025.

F7 · price: The shares were sold in multiple transactions at prices ranging from $6.00 to $6.05. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001133416-25-000026 · form4.xml · derivative · entry 1

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: comm Stock · 60,000 shares

Expires 2035-01-23

F1 · security: The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.

F2 · derivative.exercise_date: The options vest 100% on December 31, 2025.

SEC source: 0001133416-24-000074 · form4.xml · nonDerivative · entry 1

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,206

SEC source: 0001133416-23-000030 · form4.xml · derivative · entry 1

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2033-01-26

F1 · security: The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.

F2 · derivative.exercise_date: The options vest 100% on December 31, 2023.

SEC source: 0001133416-22-000037 · form4.xml · derivative · entry 1

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-01-24

F1 · security: The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan.

F2 · derivative.exercise_date: The options vest 100% on December 31, 2022.

SEC source: 0000899243-21-013811 · doc4.xml · derivative · entry 2

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2031-03-25

F1 · security: The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan.

F3 · derivative.exercise_date: Such options vest when (i) the Company has received the interim results of its NAVIGATE clinical trial and (ii) makes a public announcement that it has received the interim results.

SEC source: 0000899243-21-013811 · doc4.xml · derivative · entry 1

Shlevin Harold H. · CIK 0001557082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-03-25

F1 · security: The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan.

F2 · derivative.exercise_date: Such options vest 100% on March 31, 2022.

SEC source: 0000899243-20-001114 · doc4.xml · derivative · entry 1

Shlevin Harold H. · CIK 0001557082 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2030-01-09

F1 · security: The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan.

F2 · derivative.exercise_date: The options vest as follows: 25% on each of June 30, 2020, December 31, 2020, June 30, 2021, and December 31, 2021.

SEC source: 0001179022-19-000039 · edgar.xml · derivative · entry 2

Shlevin Harold H. · CIK 0001557082 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,294

Underlying: Common Stock · 8,706 shares

Expires 2026-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The options were originally issued on January 20, 2016 in a grant of 38,000 options which vested 25% upon grant and then approximately 792 options vested per month through January 2019.

SEC source: 0001179022-19-000039 · edgar.xml · nonDerivative · entry 1

Shlevin Harold H. · CIK 0001557082 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,706

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179022-19-000009 · edgar.xml · derivative · entry 1

Shlevin Harold H. · CIK 0001557082 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2029-01-16

F1 · derivative.exercise_date: The options vest as follows: 25% on each of June 30, 2019, December 31, 2019, June 30, 2020, and December 31, 2020.

SEC source: 0001179022-18-000051 · edgar.xml · derivative · entry 4

Shlevin Harold H. · CIK 0001557082 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,456

Underlying: Common Stock · 25,544 shares

Expires 2025-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2018.

F2 · derivative.exercise_date: The options vested as follows: 25% on January 29, 2015, the grant date, with the remainder vesting ratably on a monthly basis over a three year period.